Get the Stockscreener App
3.64
2.25%
0.08
Pre-market:
3.67
0.03
+0.82%
Alaunos Therapeutics Inc stock is traded at $3.64, with a volume of 25,695.
It is up +2.25% in the last 24 hours and up +44.44% over the past month.
Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.
See More
Previous Close:
$3.56
Open:
$3.514
24h Volume:
25,695
Relative Volume:
0.06
Market Cap:
$8.12M
Revenue:
$6,000
Net Income/Loss:
$-3.99M
P/E Ratio:
-1.4771
EPS:
-2.4643
Net Cash Flow:
$-2.85M
1W Performance:
+8.33%
1M Performance:
+44.44%
6M Performance:
+35.38%
1Y Performance:
+50.41%
1-Day Range:
$3.46
$3.69
1-Week Range:
$2.86
$3.69
52-Week Range:
$1.3137
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Name
Alaunos Therapeutics Inc
Sector
Industry
Phone
(346) 355-4099
Address
501 E LAS OLAS BLVD, FORT LAUDERDALE
Compare TCRT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
3.64 | 7.95M | 6,000 | -3.99M | -2.85M | -2.4643 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Resumed | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Stock (TCRT) Latest News
Will Alaunos Therapeutics Inc. stock outperform growth indexesEarnings Trend Report & Daily Technical Stock Forecast Reports - Newser
Will Alaunos Therapeutics Inc. stock recover faster than marketWeekly Trend Recap & Accurate Technical Buy Alerts - Newser
Is Alaunos Therapeutics Inc. stock a contrarian buy2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser
What momentum indicators show for Alaunos Therapeutics Inc. stock2025 Institutional Moves & Real-Time Volume Analysis - Newser
Alaunos Therapeutics, Inc. (TCRT) 7.38% in After-hours: Momentum Builds Amid Routine Trading - Stocks Telegraph
Alaunos Therapeutics Inc. (TCRT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Alaunos Therapeutics Inc. stock ready for breakout2025 Fundamental Recap & High Accuracy Investment Signals - newser.com
What risks investors should watch in Alaunos Therapeutics Inc. stockWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com
Is Alaunos Therapeutics Inc. stock cheap compared to fundamentalsRecession Risk & Verified High Yield Trade Plans - newser.com
Can you recover from losses in Alaunos Therapeutics Inc.CEO Change & Technical Confirmation Alerts - newser.com
Can Alaunos Therapeutics Inc. recover in the next quarterPortfolio Performance Report & Daily Volume Surge Trade Alerts - newser.com
Risk adjusted return profile for Alaunos Therapeutics Inc. analyzedSell Signal & Safe Entry Momentum Tips - newser.com
Market reaction to Alaunos Therapeutics Inc.’s recent newsQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Alaunos Therapeutics, Inc.Common Stock (Nasdaq:TCRT) Stock Quote | User | woonsocketcall.com - Markets Financial Content
News impact scoring models applied to Alaunos Therapeutics Inc.2025 Bull vs Bear & Daily Volume Surge Signals - newser.com
Evaluating Alaunos Therapeutics Inc. with trendline analysisQuarterly Risk Review & Free Weekly Watchlist of Top Performers - newser.com
How to track smart money flows in Alaunos Therapeutics Inc.Earnings Overview Report & Consistent Return Strategy Ideas - newser.com
Why Alaunos Therapeutics Inc. stock could outperform in 20252025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Ziopharm: Q3 Earnings Snapshot - New Haven Register
Custom strategy builders for tracking Alaunos Therapeutics Inc.July 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
How hedge fund analytics apply to Alaunos Therapeutics Inc. stockWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com
Alaunos Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Alaunos Therapeutics, Inc. Quarterly Earnings Report | TCRT SEC FilingForm 10-Q - Stock Titan
How analysts rate Alaunos Therapeutics Inc. stock today2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
Alaunos Therapeutics Inc Stock (TCRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):